Feb 10 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 471 mln 428 mln 400 mln
(+10.1 pct) (-4.4 pct) (-15.2 pct)
Operating loss 1.21 loss 798 mln loss 670 mln
Recurring loss 1.23 loss 796 mln loss 680 mln
Net
Net loss 1.29 loss 812 mln loss 680 mln
EPS loss 36.74 yen loss 25.56 yen loss 15.88 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T